Kedarnath Anil Kumar Agarwal's Insider Trades & SAST Disclosures
Kedarnath Anil Kumar Agarwal's most recent trade in Novelix Pharmaceuticals Ltd. was a Acquisition of 50,000 Equity Shares done at an average price of Rs. 10 . Disclosure was reported to the exchange on June 12, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Kedarnath Anil Kumar Agarwal in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trimurthi | Kedarnath Anil Kumar Agarwal | Promoter Group | Acquisition | 12 Jun 2024 | 50,000 | 50,000 (0.50%) | 0.62% | 10 | 500,000 | 11 Jun 2024 11 Jun 2024 |
Insider Trading | Equity Shares | Preferential Offer |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.